New pill combo aims to fight back against tough lung cancer
NCT ID NCT03672773
Summary
This study is testing whether taking two oral drugs together works better than either alone for people with a fast-growing type of lung cancer that has returned after initial chemotherapy. The drugs, talazoparib and temozolomide, aim to stop cancer cells from growing by damaging their DNA and preventing repair. The goal is to see if this combination can shrink tumors and control the disease for people with limited treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center
Bakersfield, California, 93309, United States
-
Cancer Center of Kansas
Wichita, Kansas, 67214, United States
-
Ft. Wayne Medical Oncology and Hematology, Inc.
Fort Wayne, Indiana, 46804, United States
-
Orlando Health, Inc. d/b/a Orlando Health UF Health Center
Orlando, Florida, 32806, United States
-
St. Joseph Heritage Healthcare
Fullerton, California, 92835, United States
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.